Loading…
Oscar Health, Inc. is projected to rise to $47.97 by 2027, a +57% move from its current price of $30.54. OSCR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $29.56 | $30.59 | $31.66 | +0.16% |
| Jul 14 | $29.19 | $30.64 | $32.16 | +0.33% |
| Jul 15 | $28.92 | $30.69 | $32.57 | +0.49% |
| Jul 16 | $28.70 | $30.74 | $32.92 | +0.65% |
| Jul 17 | $28.52 | $30.79 | $33.24 | +0.82% |
| Jul 18 | $28.36 | $30.84 | $33.54 | +0.98% |
| Jul 19 | $28.21 | $30.89 | $33.82 | +1.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $28.21 | $30.89 | $33.82 | +1.15% |
| Week 2 | $27.48 | $31.24 | $35.52 | +2.31% |
| Week 3 | $27.01 | $31.60 | $36.98 | +3.48% |
| Week 4 | $26.66 | $31.96 | $38.32 | +4.66% |
| Week 5 | $26.40 | $32.33 | $39.60 | +5.86% |
| Week 6 | $26.19 | $32.70 | $40.83 | +7.08% |
| Week 7 | $26.02 | $33.08 | $42.04 | +8.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products.
In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc.
in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Oscar Health, Inc. (OSCR) is a healthcare technology company. The asset is currently priced at $32.18, with a market cap of $9.7B and a rank of 919.
The stock trades with a bullish technical backdrop, and the thirty-day range runs from $24.88 to $41.62. The forecast shows a path to significantly higher prices over the coming years, with the average price in 2026 at $32.18 and substantial upside thereafter, reaching a 2050 average of $521.53 and a max of $1,118.43.
A major floor 64.5% below — a decisive break under it would weaken the trend.
The nearest floor, 32.9% below — buyers have tended to step in here.
The nearest ceiling, 5.4% above — a clean break opens room to run.
A major ceiling 29.1% above — clearing it would confirm fresh momentum.
Key OSCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OSCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $31.02 | Sell | $30.87 | Sell |
| MA 10 | $30.70 | Sell | $30.54 | Buy |
| MA 20 | $29.74 | Buy | $29.35 | Buy |
| MA 50 | $25.31 | Buy | $25.70 | Buy |
| MA 100 | $19.59 | Buy | $22.14 | Buy |
| MA 200 | $18.16 | Buy | $19.44 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.39 | Neutral |
| Stoch RSI (14) | 3.97 | Buy |
| CCI (20) | 47.42 | Neutral |
| Williams %R (14) | -44.81 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | 2.04 | Buy |
| Bollinger %B (20,2) | 0.66 | Neutral |
| Stochastic %K (14) | 55.19 | Neutral |
| TRIX (15) | 1.09 | Buy |
| Awesome (5,34) | 3.87 | Buy |
| Ultimate (7,14,28) | 64.51 | Neutral |
| Momentum (10) | 1.87 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 30.98 | Sell |
| ADX (14) | 32.91 | Buy |
| ATR (14) | 0.78 | Info |
The 30-day technical picture is bullish, supported by a bullish sentiment. The RSI14 is 70, while the SMA50 is $23.91 and the SMA200 is $17.84. Support sits at $20.50 and resistance at $32.18. The thirty-day range stretches from $24.88 to $41.62.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.85 | $30.54 | $49.06 | 0% | Neutral | |
| $37.28 | $47.97 | $65.80 | +57% | Bullish | |
| $42.73 | $56.99 | $81.76 | +87% | Bullish | |
| $51.54 | $70.84 | $105.22 | +132% | Bullish | |
| $50.38 | $71.11 | $108.75 | +133% | Bullish | |
| $54.63 | $79.02 | $123.95 | +159% | Bullish | |
| $69.07 | $102.24 | $164.02 | +235% | Bullish | |
| $82.13 | $124.22 | $203.39 | +307% | Bullish | |
| $97.70 | $150.86 | $251.67 | +394% | Bullish | |
| $102.19 | $160.95 | $273.21 | +427% | Bullish | |
| $166.70 | $287.74 | $524.93 | +842% | Bullish | |
| $268.19 | $545.02 | $1,103.04 | +16.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.85 | $30.54 | $38.01 | +0.00% |
| August 2026 | $28.89 | $34.34 | $42.06 | +12.43% |
| September 2026 | $29.55 | $35.43 | $44.01 | +3.19% |
| October 2026 | $29.43 | $35.55 | $44.67 | +0.35% |
| November 2026 | $30.44 | $37.02 | $46.97 | +4.12% |
| December 2026 | $31.33 | $38.33 | $49.06 | +3.53% |
Click any year to see its month-by-month OSCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Oscar Health, Inc.'s 2026 outlook centres on $30.54, within a $10.85 to $49.06 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, OSCR could reach as high as $65.80, with a base case around $47.97 and support toward $37.28 — roughly +57% from $30.54. Buyers look set to stay in control over this stretch.
Expect OSCR to range from $42.73 to $81.76 through 2028. The $56.99 average target implies a +87% move from current prices. That is up +19% on the projected 2027 average. Momentum favours further upside here.
The OSCR price prediction for 2029 points to an average of $70.84 (low $51.54, high $105.22) — a potential gain of +132% on today's $30.54. Buyers look set to stay in control over this stretch.
In 2030, OSCR is projected to trade between $50.38 and $108.75, averaging $71.11 — a potential gain of +133% from today's $30.54. That is up 0% on the projected 2029 average. Momentum favours further upside here.
Oscar Health, Inc.'s 2031 outlook centres on $79.02, within a $54.63 to $123.95 range. That is up +11% on the projected 2030 average. That marks a +159% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, OSCR could reach as high as $164.02, with a base case around $102.24 and support toward $69.07 — roughly +235% from $30.54. Momentum favours further upside here.
Expect OSCR to range from $82.13 to $203.39 through 2033. The $124.22 average target implies a +307% move from current prices. That is up +21% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The OSCR price prediction for 2034 points to an average of $150.86 (low $97.70, high $251.67) — a potential gain of +394% on today's $30.54. Momentum favours further upside here.
In 2035, OSCR is projected to trade between $102.19 and $273.21, averaging $160.95 — a potential gain of +427% from today's $30.54. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Oscar Health, Inc.'s 2040 outlook centres on $287.74, within a $166.70 to $524.93 range. That is up +79% on the projected 2035 average. That marks a +842% change versus current levels. Momentum favours further upside here.
By 2050, OSCR could reach as high as $1,103.04, with a base case around $545.02 and support toward $268.19 — roughly +16.8x from $30.54. Buyers look set to stay in control over this stretch.
Investing $1,000 in OSCR today (≈ 32.743942 OSCR) could be worth
$17,846.23
+$16,846.23 (+1685%) by 2050 · US Dollar
Based on the average projected OSCR price of $545.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OSCRwould be worth at today's price.
$1,000 invested in OSCR on Jul 10, 2025 (≈ 64.391501 OSCR) would be worth
$1,966.52
+$966.52 (+96.7%) today · 1.97× · US Dollar
Based on a OSCR entry price of $15.53 vs. today's $30.54.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $32.18 | $949.04 | -5.1% |
| 1 month ago | $27.85 | $1,096.59 | +9.7% |
| 3 months ago | $14.45 | $2,113.49 | +111.3% |
| 6 months ago | $17.66 | $1,729.33 | +72.9% |
| 1 year ago | $15.53 | $1,966.52 | +96.7% |
| All time (5.0y) ago | $19.07 | $1,601.47 | +60.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OSCR forecast.
Our base-case forecast reaches $61.00 around 2029.
Implied market cap at $61.00: $16.22B
The multi-year forecast shows a bullish trajectory across the horizon. In 2026 the average price is $32.18 with an ROI of 0% and a neutral sentiment, followed by 2027 at $50.38 with a 56.6% ROI and a bullish sentiment, and 2028 at $59.73 with an 85.6% ROI and a bullish sentiment. The path continues with 2029 at $72.69 (125.9% ROI) and 2030 at $70.61 (119.4% ROI).
Further years show continued upside: 2031 at $79.75 (147.8% ROI), 2032 at $105.84 (228.9%), 2033 at $127.72 (296.9%), 2034 at $154.55 (380.3%), 2035 at $160.97 (400.2%). The projection accelerates into the 2040s, with 2040 at $295.92 (819.6% ROI) and 2050 at $521.53 (1520.7% ROI). All through, the sentiment is bullish.
Tap a question to reveal the answer.
Avg $70.61; min $48.40; max $111.70; ROI 119.4%; sentiment BULLISH.
The forecast shows a bullish trajectory with rising averages from 2027 onward, including 2027 avg $50.38, 2028 avg $59.73, 2029 avg $72.69, and long-run 2040 avg $295.92 with ROI 819.6% and 2050 avg $521.53 with ROI 1520.7%; sentiment BULLISH.
Yes. The max forecast shows 2033 max $217.72 and 2034 max $268.89, indicating prices above $200 are projected.
Current price is $32.18 and market cap is $9.7B.
The 30-day range is $24.88 to $41.62.
Oscar Health, Inc. Community Discussion
0Share your Oscar Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.